NFE2L2 and hepatocellular carcinoma: Sun X et al. documented a central role for the NRF2/HMOX-1 pathway in protecting hepatocellular carcinoma cells from ferroptosis since Hmox-1 knockdown enhanced cell growth inhibition induced by erastin (one of the ferroptosis inducers) and sorafenib (Sun et al., 2016).